Microangiopathic glomerulopathy in children with sickle cell anemia

Pediatric Pathology and Laboratory Medicine

Volumn 16, Issue 2, 1996, Pages 275-284

  Vogler, Carole ^a,b   Wood, Ellen ^a,b   Lane, Pascale ^a,c   Ellis, Eileen ^a,b,c   Cole, Barbara ^a,b,c   Thorpe, Constance ^a,b,c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

microangiopathic glomerulopathy; secondary membranoproliferative glomerulonephritis; sickle cell anemia

Indexed keywords

CANNABIS; COCAINE; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; DIGOXIN; ENALAPRIL; FUROSEMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OXYGEN; PREDNISONE; PROPERDIN; PROTEIN;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CONGESTIVE HEART FAILURE; ECHOGRAPHY; EDEMA; ELECTRON MICROSCOPY; FEMALE; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROTEINURIA; SICKLE CELL ANEMIA; TRANSFUSION;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD, PRESCHOOL; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0029965715     PISSN: 10771042     EISSN: None     Source Type: Journal    
DOI: 10.1080/107710496175750     Document Type: Article

References (26)

1. Bernstein J, Whitten CF. A histologie appraisal of the kidney in sickle cell anemia. Arch Pathol 1960:70:407-18.
2. Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D. Renal lesions in sickle cell nephropathy in children. Nephron 1985:39:352-55.
3. Bakir AA, Hathiwala SC, Ainis H, et al. Prognosis of the nephrotic syndrome in sickle glomerulopathy. Am J Nephrol 1987:7:110-15.
4. Rennke HG. Secondary membranoproliferative glomerulonephritis. Kidney Int 1995;47:643-56.
5. Iskandar SS, Morgann RG, Browning MC, Lorentz WB. Membranoproliferative glomerulonephritis associated with sickle cell disease in two siblings. Clin Nephrol 1991:35:47-51.
6. Akaoka K, White RHR, Raafat F. Human glomerular growth during childhood: A morphometric study. J Pathol 1994:173:261-8.
7. Moore L, Williams R, Staples A. Glomerular dimensions in children under 16 years of age. J Pathol 1993:171:145-50.
8. Elfenbein IB, Patchefsky A, Schwartz W, Weinstein AG. Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am J Pathol 1974:77:357-76.
9. Falk RJ, Jennette JC. Sickle cell nephropathy. Adv Nephrol 1994;23:133-47.
10. Bourke E. The kidney in sickle cell anemia. J Assoc Acad Minor Phvs 1992:3:41-5.
11. Zamurovic D, Churg J. Idiopathic and secondary mesangiocapillary glomerulonephritis. Nephron 1984:38:145-53.
12. Strauss J, Pardo V, Koss MN, Griswold W, Mclntosh RM. Nephropathy associated with sickle cell anemia: An autologous immune complex nephritis. Am J Med 1975:58:382-7.
13. Bhathena DB, SondheimerJH. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: Morphology and pathogenesis. J Am Soc Nephrol 1991:1:1241-52.
14. Bjornson AB. The immune deficit. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven, 1994;335-48.
15. Hand WL, King NL. Serum opsonization of salmonella in sickle cell anemia. Am J Med 1978:64:388-95.
16. McCoy RC. Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. I.ab Invest 1969:21:85-95.
17. Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992:326:910-5.
18. Longenecker GL. Pharmacologic manipulation of sickle red cell adhesion to vascular endothelium. In: Ohnishi ST, Ohnishi T, eds. Membrane Abnormalities in Sickle Cell Disease and in Other Red Blood Cell Disorders. Boca Raton, FL: CRC Press, 1994; 189-216.
19. Kaul DK. Flow properties and endothelial adhesion of sickle erythrocytes in an ex vivo microvascular preparation. In: Ohnishi ST, Ohnishi T, eds. Membrane Abnormalities in Sickle Oil Disease and in Other Red Blood Cell Disorders. Boca Raton, FL: CRC Press, 1994;217-41.
20. Francis RB, Hebbel RP. Hemostasis. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven, 1994;299-310.
21. Weidner N, Buckalew VM. Sickle cell anemia, sickle cell trait and polycythemic states. In: Tisher CC, Brenner BM, eds. Renal Pathology with Clinical and Functional Correlations. 2nd ed. Philadelphia: J. B. Lippincott, 1994:1491-510.
22. Alleyne GAO, Van Eps I.WS, Addae SK, Nicholson GD, Scheuten H. The kidney in sickle cell anemia. Kidney Int 1975:7:371-9.
23. Burke JR, Glasgow EF, McCredie DA, Powell HR. Nephropathy in cyanotic congenital heart disease. Clin Nephrol 1977;7:38-42.
24. Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990;150:501-4.
25. Tomson C. Endstage renal disease in sickle cell disease: Future directions. Postgrad Med J 1992; 68:775-8.
26. Lane PH. Furosemide treatment, angiotensin II, and renal growth and development in the rat. Pediatr Res 1995:37:747-54.